Accelerated Monoclonal Antibody Development: Advance From Transfection To GMP Drug Substance In 9 Months
Source: MilliporeSigma
Hear from some of the experts who were instrumental in developing the Accelerated mAb development program and work with our biotech clients on a daily basis to accelerate their timelines toward the production of GMP drug substances.
In this webinar, you will learn:
- The strategies used in the Accelerated mAb development program that allow clients to rapidly advance to GMP drug substance production with confidence
- The time and cost savings that can be achieved using streamlined unit operations and scale-up processes
- How the analytical package was designed to be phase-appropriate and accelerate timelines
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more